Thursday, February 27, 2020

Pharma giant Sanofi announces next generation basal ‘Insulin Glargine U300’ in Pakistan

Featured

US official: Corona’s outbreak will not change China’s commitment to buy US goods

A senior US Treasury official said on Thursday that the US government expects China to fulfill its commitment to...

China: Corona virus death toll rises to 2239, and 75,567 infections

China’s National Health Committee announced on Friday that it has received reports of 889 new confirmed cases of the...

A major reshuffle in the British Government

Several British government ministers have been fired in a drastic reshuffle by Prime Minister Boris Johnson. The list includes...
Zubair Yaqoob
Zubair Yaqoob
The author has diversified experience in investigative journalism. He is Chief content editor at wnobserver.com He can be reached at: [email protected]
Sanofi, a French multinational pharmaceutical company with strong roots in Pakistan has announced the next generation basal insulin “insulin glargine U300” in Pakistan at a scientific event attended by leading doctors.

 

The control of blood sugar levels in patients with diabetes remains suboptimal, with many patients on treatment for diabetes not reaching their blood sugar level goals. Sanofi’s new basal insulin, designed to act over 24 hours, seeks to address this unmet need to improve the control of blood sugar in adults living with diabetes. This basal insulin was approved by FDA in 2015 and since then the drug has been introduced in many countries, including the US, Canada, Russia, Japan and India.

 

Sanofi’s insulin glargine U300 works like the human body’s natural insulin and helps control blood sugar along with diet and exercise. The new insulin promises stable blood sugar control throughout the day and night, offering dosage flexibility and providing empowerment to patients.

 

Country Chair and General Manager, Sanofi Pakistan, Asim Jamal  emphasized that “Sanofi is proud of its century-long heritage in diabetes research and development. We have been empowering people living with diabetes in Pakistan for over 50 years through oral therapies and for over a decade with insulin therapies. It is our endeavor to bring innovative solutions to patients to improve their health while our team of dedicated Diabetes Educators strives to empower people with diabetes to manage their condition efficiently and live active, full lives. We remain committed to bringing advanced therapies to Pakistan, delivering better health outcomes for people with diabetes.”

 

International experts on diabetes management shared their experience and expertise with local doctors, addressing topics that would help local clinicians to make well informed decisions for their diabetes patients taking multiple factors into consideration.

 

Professor at the Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland Dr. Leszek Czupryniak, in a presentation ‘An insulin of today for a steady tomorrow’, said that nearly 50% of people living with diabetes remain uncontrolled. Despite the proven efficacy of insulin, ensuring effective titration and maintenance can be a challenge – mostly due to the risk of hypoglycemia and the insulin being launched provides a new option. Insulin glargine U300 takes the benefits of insulin to the next level, thus providing physicians a better tool to empower their diabetic patients, offering them insulin with lowest risk of hypoglycemia and being safest in reaching optimal glucose control.

 

Manufactured at Sanofi’s ‘Insulin City’ in Germany, the product is available at all over the country on prescription.

 

 

Zubair Yaqoob
Zubair Yaqoob
The author has diversified experience in investigative journalism. He is Chief content editor at wnobserver.com He can be reached at: [email protected]

Latest News

Breaking: Malaysian PM Dr Mahathir submits resignation to the King

Dr Mahathir Mohamad has sent his resignation letter as Prime Minister of Malaysia today. According to the Prime Minister's Office,...

Trump adviser Roger Stone sentenced to 3 years in prison for lying

A federal judge issued a ruling on Thursday against Roger Stone, a longtime adviser to US President Donald Trump, to three years and four...

US official: Corona’s outbreak will not change China’s commitment to buy US goods

A senior US Treasury official said on Thursday that the US government expects China to fulfill its commitment to purchase more US goods under...

Voting begins in Iran’s parliamentary elections

The Iranians began voting on Friday in a parliamentary election that is unlikely to change Tehran's troubled relations with the United States, after excluding...

Austrian Parliament: There is no place for ISIS operatives in the country

Herbert Kickel, head of the Parliamentary Bloc of the Freedom Party (the third largest Austrian party), confirmed that anyone who joined the terrorist group...

Related News